← Back to Search

Heart to Heart for High Blood Pressure

N/A
Recruiting
Research Sponsored by Rush University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants: Age 18 or older
Participants: Has blood pressure readings with uncontrolled blood pressure, defined as exceeding the blood thresholds for initiation of antihypertensive medication according to the 2017 American College of Cardiology/ American Heart Association (ACC/AHA) guidelines
Must not have
Participants: Has a medical condition that prohibits or severely restricts ability to eat vegetables (i.e., renal disease, Crohn's disease)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at baseline and 6 months and 12 months after start of the intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether a church-based intervention can reduce blood pressure in African Americans with uncontrolled blood pressure.

Who is the study for?
This trial is for African American adults with uncontrolled high blood pressure who attend church regularly and can join weekly Zoom meetings. Eligible churches must have a majority of African American members and be able to recruit participants. People unable to make dietary changes or give informed consent, planning to move soon, or with certain medical conditions are excluded.
What is being tested?
The study tests 'Heart to Heart', a heart health intervention, and 'Money Smart', a financial wellness program in churches over 12 months. It's randomized, meaning participants are put into groups by chance to compare the effects on blood pressure control among African Americans.
What are the potential side effects?
Since this trial focuses on behavioral interventions like education and lifestyle changes rather than medication, side effects may include discomfort from lifestyle adjustments or stress from participating in regular meetings.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
My blood pressure is higher than the recommended levels.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot eat vegetables due to a severe medical condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at baseline and 6 months and 12 months after start of the intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at baseline and 6 months and 12 months after start of the intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Blood pressure
Secondary study objectives
Change in Barriers to medication use
Change in DASH diet adherence
Change in Hypertension knowledge
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Heart to HeartExperimental Treatment1 Intervention
Group II: Money SmartActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Heart to Heart
2012
Completed Phase 1
~100

Find a Location

Who is running the clinical trial?

Rush University Medical CenterLead Sponsor
436 Previous Clinical Trials
248,940 Total Patients Enrolled

Media Library

Heart to Heart Clinical Trial Eligibility Overview. Trial Name: NCT05220332 — N/A
High Blood Pressure Research Study Groups: Heart to Heart, Money Smart
High Blood Pressure Clinical Trial 2023: Heart to Heart Highlights & Side Effects. Trial Name: NCT05220332 — N/A
Heart to Heart 2023 Treatment Timeline for Medical Study. Trial Name: NCT05220332 — N/A
~48 spots leftby Jul 2025